Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Novo Nordisk (NVO) has been upgraded to Outperform from Market Perform at Bernstein, citing the growth potential within the company's obesity franchise. Analys...
Bernstein analyst Florent Cespedes upgraded Novo Nordisk (NVO) to Outperform from Market Perform with a price target of DKK 540, down from DKK 620. The stock ha...
Issuing a preliminary report on the value of GLP-1 drugs, drug pricing watchdog the Institute for Clinical and Economic Review (ICER) said on Tuesday that popul...
Analyst ratings
50%
of 32 ratingsMore NVO News
BofA notes that the Institute for Clinical and Economic Review released its updated draft report for obesity drugs and now says the GLP-1 class as a whole are c...
Hims & Hers (HIMS) stock rose 2.6% on Monday after the U.S. Food and Drug Administration (FDA) released a “green list” of overseas suppliers of GLP-1 ingredient...
...
Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S NVO and Eli Lilly And Co LLY achieve a combined m...
China-based drugmakers that once fueled a surge of copycat weight-loss treatments in the U.S. are now pivoting to generics of Novo Nordisk‘s NVO Wegovy and Eli...
